Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
The 2027-2032 World Outlook for Life Sciences
US$ 1,195.00
This study covers the world outlook for life sciences across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th...
January 2026
288 pages
The 2027-2032 World Outlook for Lifestyle Drugs
US$ 1,195.00
This study covers the world outlook for lifestyle drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Liothyronine
US$ 1,195.00
This study covers the world outlook for liothyronine across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Lipid Disorder Treatments
US$ 1,195.00
This study covers the world outlook for lipid disorder treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Lipopeptide MRSA Drugs
US$ 1,195.00
This study covers the world outlook for lipopeptide MRSA drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Liposomal Doxorubicin
US$ 1,195.00
This study covers the world outlook for liposomal doxorubicin across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Live Vaccines
US$ 1,195.00
This study covers the world outlook for live vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th...
January 2026
287 pages
The 2027-2032 World Outlook for Liver Cirrhosis Drugs
US$ 1,195.00
This study covers the world outlook for liver cirrhosis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Local Anesthesia Drugs
US$ 1,195.00
This study covers the world outlook for local anesthesia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Lupus Drugs
US$ 1,195.00
This study covers the world outlook for lupus drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Lupus Therapeutics
US$ 1,195.00
This study covers the world outlook for lupus therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Lymphoma Treatments
US$ 1,195.00
This study covers the world outlook for lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Lyophilized Injectable Drugs
US$ 1,195.00
This study covers the world outlook for lyophilized injectable drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Lysosomal Disease Treatments
US$ 1,195.00
This study covers the world outlook for lysosomal disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Lysosomal Storage Diseases
US$ 1,195.00
This study covers the world outlook for lysosomal storage diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
287 pages
The 2027-2032 World Outlook for Macrolide Antibiotics
US$ 1,195.00
This study covers the world outlook for macrolide antibiotics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Macrolide Drugs
US$ 1,195.00
This study covers the world outlook for macrolide drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Male Hypogonadism
US$ 1,195.00
This study covers the world outlook for male hypogonadism across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Marine Derived Drugs
US$ 1,195.00
This study covers the world outlook for marine derived drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Medical Affairs Outsourcing
US$ 1,195.00
This study covers the world outlook for medical affairs outsourcing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
287 pages
The 2027-2032 World Outlook for Medical Morphine
US$ 1,195.00
This study covers the world outlook for medical morphine across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Medication Adherence
US$ 1,195.00
This study covers the world outlook for medication adherence across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Meningitis Vaccines
US$ 1,195.00
This study covers the world outlook for meningitis vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Men's Health Therapeutics
US$ 1,195.00
This study covers the world outlook for men's health therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Metabolism Drugs
US$ 1,195.00
This study covers the world outlook for metabolism drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Migraine Drugs
US$ 1,195.00
This study covers the world outlook for migraine drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
The 2027-2032 World Outlook for Migraine Treatments
US$ 1,195.00
This study covers the world outlook for migraine treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Mono Hepatitis B Vaccines
US$ 1,195.00
This study covers the world outlook for mono hepatitis B vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Motion Sickness Treatments
US$ 1,195.00
This study covers the world outlook for motion sickness treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
288 pages
The 2027-2032 World Outlook for Mouth Ulcer Drugs
US$ 1,195.00
This study covers the world outlook for mouth ulcer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Mouth Ulcer Treatment Sprays
US$ 1,195.00
This study covers the world outlook for mouth ulcer treatment sprays across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
288 pages
The 2027-2032 World Outlook for Mouth Ulcers Treatments
US$ 1,195.00
This study covers the world outlook for mouth ulcers treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for MRSA Drugs
US$ 1,195.00
This study covers the world outlook for MRSA drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the c...
January 2026
287 pages
The 2027-2032 World Outlook for Multiple Sclerosis Drugs
US$ 1,195.00
This study covers the world outlook for multiple sclerosis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Muscle Relaxants
US$ 1,195.00
This study covers the world outlook for muscle relaxants across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
